The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.

Source:http://linkedlifedata.com/resource/pubmed/id/15254749

Download in:

View as

General Info

PMID
15254749